morbid obesity & bariatric surgery: what do we know?

42
Morbid Obesity & Bariatric Surgery: What do we know? Jessica Gonzalez Hernandez MD Bariatric, MIS and General Surgeon Saturday, July 18, 2020

Upload: others

Post on 19-Apr-2022

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Morbid Obesity & Bariatric Surgery: What do we know?

Morbid Obesity& Bariatric Surgery: What do we know?

Jessica Gonzalez Hernandez MD

Bariatric, MIS and General Surgeon

Saturday, July 18, 2020

Page 2: Morbid Obesity & Bariatric Surgery: What do we know?

Outline

• Definition

• Prevalence

• Consequences of Obesity

• Causes

• Treatment options

• Benefits, Risks and Outcomes

• Types of Bariatric Surgery

• Questions

Page 3: Morbid Obesity & Bariatric Surgery: What do we know?

Question #1

1. What is the most common etiology of morbid obesity?

a. Genetic

b. Behavioral

c. Environmental

d. All of the above

Page 4: Morbid Obesity & Bariatric Surgery: What do we know?

What is obesity?

• A disease of excess fat storage that increases the risk for serious health problems.

• BMI > 30

• Multifactorial Etiology

• 39.8% of US adults in 2015-2016

• Economic burden of obesity• $254 billion in 2013

Page 5: Morbid Obesity & Bariatric Surgery: What do we know?

What is Body Mass Index (BMI)?

• According to the National Institute of Health, BMI is a measure of body fat.

• Morbid obesity is defined as:• BMI ≥ 40

• BMI ≥ 35 with ≥ 1 comorbid conditions such as: • Hypertension

• Diabetes

• Sleep Apnea

• Hyperlipidemia

• Coronary Artery Disease

Page 6: Morbid Obesity & Bariatric Surgery: What do we know?

Obesity Trends Among US Adults 1985-2010

No Data <10% 10%–14% 15%–19% 20%–24% 25%–29% ≥30%

1990

2000 2010

1985

Page 7: Morbid Obesity & Bariatric Surgery: What do we know?

Prevalence of Self-Reported Obesity Among US Adults 2017

Page 8: Morbid Obesity & Bariatric Surgery: What do we know?

Prevalence

Page 9: Morbid Obesity & Bariatric Surgery: What do we know?

Consequences of Obesity

Page 10: Morbid Obesity & Bariatric Surgery: What do we know?

Causes

• Increased access to processed andrefined, high-energy food anddrink.

• Regular consumption of fast food• high in saturated and trans fats and

low in essential fiber, micronutrients,and antioxidants

• Vulnerability to food advertising• even if exposure is brief, and heavy

television use has been associatedwith higher reported junk foodconsumption

• Slight increases in calorificconsumption or small reductions inenergy expenditure• can lead to marked body mass

increases in the long term

• Genetic variations causing leptinresistance• shown to cause an excessive appetite

and early obesity.

Page 11: Morbid Obesity & Bariatric Surgery: What do we know?

Treatment Options

1. Dietary and Lifestyle Interventions

2. Pharmacological Interventions

3. Surgical Intervention

Page 12: Morbid Obesity & Bariatric Surgery: What do we know?

Dietary and Lifestyle Interventions

• Dietary Intake• Limit consumption of sugar sweetened

beverages• Encourage fruits and vegetables

• Physical Activity• Encourage 60 min moderate to vigorous

physical activity/day

• Eating behaviors• Daily breakfast• Limit restaurant eating • Encourage family meals • Limit portion size

• Reports on such interventions haveillustrated the inevitable relapse inmost patients who achieve weight lossby these methods.

• Up to two-thirds of patients regainmore weight than was initially lost.

Page 13: Morbid Obesity & Bariatric Surgery: What do we know?

Lifestyle Changes for Successful Weight Loss

• Focus on protein and whole solid foods at every meal

• Take marble-sized bites and chew thoroughly, eat slowly

• Use small plates, small utensils

• Measure your foods

• Do not drink during or 30 minutes after meals

• Avoid liquid calories and CARBONATED BEVERAGES

• Exercise!

• Keep a food and exercise diary

Page 14: Morbid Obesity & Bariatric Surgery: What do we know?

Pharmacological Interventions

• Phentermine

• Liraglutide

• Naltrexone/bupropion

• Lorcaserin

• Orlistat• The only broadly available obesity drug• Intestinal lipase inhibitor• MOA: inhibit GI fat absorption by up to 30%• Modest BMI reductions - 4.2 kg/m2 at best

• Metformin• Shown to result in moderate weight and BMI reductions in overweight adolescents• Reports on reductions in BMI - 3.2 kg/m2

Page 15: Morbid Obesity & Bariatric Surgery: What do we know?

Bariatric Surgery

• Most effective and durable treatment formorbid obesity• Achieving considerable weight loss• Enabling maintenance of weight loss in the

long term• Induction of remission of comorbidities• Improvement in long-term mortality

• Patients with a BMI > 30 have a 50-100% increased risk of premature death

• Bariatric surgery increases lifespan by reducing the risk of premature death by 30-40%

• Weight loss results

• As much as 60% of excess weight 6 months after surgery

• As much as 77% of excess weight as early as 12 months after surgery

• On average, 5 years after surgery, patients maintain 50% of their excess weight loss.

• Risk of surgery

• Death 0.1% (1/1000)

• Major complication 4%

Page 16: Morbid Obesity & Bariatric Surgery: What do we know?

Question #2

3. What is the gold standard surgical procedure for weight loss?

a. Duodenal Switch

b. Sleeve gastrectomy

c. Roux en Y gastric bypass

d. Gastric banding

Page 17: Morbid Obesity & Bariatric Surgery: What do we know?

Bariatric Surgery

• First attempts 1950s

• Classification• Restrictive

• Malabsorptive

• RYGB is to many the gold standard bariatricprocedure with excellent outcomes forexcess weight loss, comorbidity resolution,and eating function, with acceptable ratesof morbidity and mortality.

Page 18: Morbid Obesity & Bariatric Surgery: What do we know?

Medical Outcomes

86

79

86

7977

62

84

62

0

10

20

30

40

50

60

70

80

90

100

Type 2 Diabetes Hypertension Sleep Apnea HighCholesterol

% Resolved or Improved % Resolved

Page 19: Morbid Obesity & Bariatric Surgery: What do we know?

Bariatric Surgery

• Currently, the most commonoperations being performedsevere obesity are• Roux-en-Y gastric bypass• Vertical sleeve gastrectomy• Adjustable gastric banding *

• The goal of bariatric surgery is toprovide the most benefitpossible with the lowest risk.

Page 20: Morbid Obesity & Bariatric Surgery: What do we know?

Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP)• MBSAQIP

• ACS + ASMBS = combined their national bariatricsurgery accreditation programs into a singleunified program to achieve one nationalaccreditation standard for bariatric surgery centers

• works to advance safe, high-quality care forbariatric surgical patients through theaccreditation of bariatric surgical centers

• A bariatric surgical center achieves accreditationfollowing a rigorous review process during which itproves that it can maintain certain physicalresources, human resources, and standards ofpractice.

• All accredited centers report their outcomes tothe MBSAQIP database.

Page 21: Morbid Obesity & Bariatric Surgery: What do we know?

Question #3

2. A 40 year old female with history of hypertension and hyperlipidemia comes requesting a referral to a weight loss surgery center. What should her BMI be to a good candidate for weight loss surgery?

a. BMI > 25

b. BMI ≥ 30

c. BMI ≥ 35

d. BMI ≥ 40

Page 22: Morbid Obesity & Bariatric Surgery: What do we know?

ASMBS Selection Criteria

• BMI ≥ 35 kg/m2 with ≥ 1obesity-related co-morbidities• such as type 2 diabetes,

hypertension, sleep apnea, non-alcoholic fatty liver disease,osteoarthritis, gastrointestinaldisorders, or heart disease.

• BMI ≥ 40 kg/m2 or > 100 poundsoverweight

• Despite the minimum BMIcriteria, many insurancecompanies will not coverbariatric surgical procedures orthey may have different criteriaor only cover a certain specificprocedure.

Page 23: Morbid Obesity & Bariatric Surgery: What do we know?

Laparoscopic Surgery

• Less pain

• Faster recovery

• Shorter hospital stay

Page 24: Morbid Obesity & Bariatric Surgery: What do we know?

Sleeve Gastrectomy

• 80% of the stomach is removed• Remaining stomach looks like a

banana

• Weight loss occurs because:• Sleeve holds smaller amount of

food

• Effect of surgery on gut hormones impacting hunger, satiety & blood sugar control

Page 25: Morbid Obesity & Bariatric Surgery: What do we know?

Sleeve Gastrectomy

Advantages

• Weight loss: > 50% of excess weight

• Restricts the amount of food thestomach can hold

• Requires no foreign objects (AGB) &no bypass

• Causes favorable changes in guthormones that suppress hunger,reduce appetite and improve satiety

Disadvantages

• Is a non-reversible procedure

• Has the potential for long-term vitamin deficiencies

• GERD/Heartburn

• Leak

Page 26: Morbid Obesity & Bariatric Surgery: What do we know?

Roux-En-Y Gastric Bypass

• Gold standard of weight loss surgery

• Malabsorptive and Restrictive (2 parts)

1. Small stomach pouch: 30 mL or 1 oz

2. Intestinal bypass: divide the intestine and connect itto the pouch & reconnect the intestines lower downso that stomach acids and digestive enzymes willeventually mix with food

• Weight loss occurs because:

• Small stomach pouch restricts food intake

• Less absorption of calories & nutrients by smallpouch and intestine that is bypassed

• Changes in gut hormones for suppressing hunger,feeling full & blood sugar control

Page 27: Morbid Obesity & Bariatric Surgery: What do we know?

Roux-En-Y Gastric Bypass

Advantages

• Weight loss: 60-80% of excess weight

• Restricts the amount of food that can be consumed

• May lead to conditions that increase energy use

• Produces favorable changes in gut hormones that reduce appetite and enhance satiety

• Typical maintenance of > 50% excess weight loss

Disadvantages

• Technically a more complex operation

• Dumping syndrome

• Can lead to long-term vitamin & mineral deficiencies, especially in vitamin B12, iron, calcium and folate• Requires staying on a strict diet & lifelong

vitamin & mineral supplementation

• Leak

• Intestinal blockage (bowel obstruction, internal hernia)

Page 28: Morbid Obesity & Bariatric Surgery: What do we know?

Comparison

Type of Surgery RY Gastric Bypass Gastric Banding Sleeve Gastrectomy

Longevity Since 1970s Since 20012009 approved as a 1ary

procedure

Weight loss 55-70% 40% 50-60%

Reversible Yes Yes No

Average OR time 1-3 hours 1-2 hours 1-2 hours

Hospital stay 1-3 1-3 0-1

Mortality Risk 0.4% 0.1% 0.1%

Pros • Rapid and more total weight loss• Most commonly studied procedure• Rapid improvement or resolution of

weight related comorbidities• 85% remission of diabetes

• Least invasive• No stomach stapling or intestinal

rerouting• Fast recovery time

• No device is implanted• Simpler than gastric bypass• No intestinal rerouting

Cons • Potential for nutritional and vitamindeficiency

• “Dumping syndrome”

• Weight loss is modest in 20% of patients

• Foreign body

• Acid reflux may develop later• Not reversible• Long term data is limited

Page 29: Morbid Obesity & Bariatric Surgery: What do we know?

General Risks of Bariatric Surgery

• Infection

• Bleeding

• Leaks

• Vomiting and nausea

• Dehydration*

• Constipation or diarrhea*

• Chest pain

• Gallstones*

• Obstruction*

• Stretching of the stomach*

• Nutritional/vitamin deficiencies*

Page 30: Morbid Obesity & Bariatric Surgery: What do we know?

Part 2: Morbid Obesity & Bariatric Surgery: What do we know?

Jessica Gonzalez Hernandez MD

Bariatric, MIS and General Surgeon

Saturday, July 18, 2020

Page 31: Morbid Obesity & Bariatric Surgery: What do we know?

Vitamin Supplementation

• Sleeve gastrectomy• Multivitamin with minerals

• Not gummies

• Chewable or liquid preferred

• Vitamin B12

• Calcium with Vitamin D

• RY Gastric Bypass• Multivitamin with minerals

• Not gummies

• Chewable or liquid preferred

• Vitamin B12

• Calcium with Vitamin D

• Iron

• Vitamin C

Page 32: Morbid Obesity & Bariatric Surgery: What do we know?

Follow up Laboratories: 6 months

• Sleeve gastrectomy• CBC• CMP• Folate• PTH• Iron and transferrin

• Vitamin B12• Vitamin D, 25-OH

• RY Gastric Bypass• CBC• CMP• Folate• PTH• Iron and transferrin• Magnesium• Phosphorus• Zinc• Copper• Vitamin B12• Vitamin D, 25-OH

Page 33: Morbid Obesity & Bariatric Surgery: What do we know?

Follow up Laboratories: 12 months & Annual

• Sleeve gastrectomy• CBC• CMP• Folate• PTH• Iron and transferrin

• Vitamin B12• Vitamin D, 25-OH

• RY Gastric Bypass• CBC• CMP• Folate• PTH• Iron and transferrin• Magnesium• Phosphorus• Zinc• Copper• Vitamin B12• Vitamin D, 25-OH• Bone density: dual photon study

Page 34: Morbid Obesity & Bariatric Surgery: What do we know?

Deficiencies

• Hypocalcemia • S/S - tetany and cramping

• Dx - total and ionized serum calcium levels and PTH

• Tx - oral supplements of calcium citrate 1200 to 1500mg/d

• Protein deficiency • S/S - edema, weakness, decreased

muscle mass, thinning hair

• Dx - serum albumin, prealbumin, creatinine

• Tx - increasing oral protein supplements• Refractory - may need enteral or

parenteral nutritional support

Page 35: Morbid Obesity & Bariatric Surgery: What do we know?

Deficiencies

• Vitamin B12 deficiency • S/S – fatigue (pernicious anemia) and

neurologic symptoms, such as tingling or numbness in fingers and toes, ataxia, mood changes, memory loss, dementia

• Dx – CBC, serum B12 levels

• Tx - oral or sublingual B12 (500 ug/d) for 1 month • Refractory - intramuscular injections of

B12 (1000–2000 ug/month) for 2 to 3 months.

• Iron deficiency • S/S - anemia (fatigue, pale skin,

palpitations, cold hands and feet)

• Dx - CBC, serum iron, iron-binding capacity, ferritin

• Tx - ferrous sulfate 300 mg BID to TID with vitamin C• Refractory - intravenous iron infusions

Page 36: Morbid Obesity & Bariatric Surgery: What do we know?

Deficiencies

• Vitamin D deficiency • S/S – hypocalcemia

• Dx - low 25-hydroxy vitamin D level

• Tx - oral vitamin D, 50,000 IU once weekly for 3 months, which is increased to 50,000 IU twice a week for another 3 months if still deficient• Refractory - oral calcitriol vitamin D

1000 IU/d.

• Folate deficiency • S/S - macrocytic anemia and

neural tube defects in pregnant post-bariatric surgery patients

• Dx - CBC, serum folate levels, and homocysteine levels

• Tx - Oral repletion with 400 mg/d (included in multivitamin) for 1 month• Refractory – increase dosage to 1200

mg/d.

Page 37: Morbid Obesity & Bariatric Surgery: What do we know?

Deficiencies

• Zinc deficiency • S/S - poor wound healing, hair

loss, diarrhea, and alteration in taste.

• Dx - low levels of serum zinc

• Tx - oral zinc 220 mg/d for 1 month. • Refractory – increase dosage to 220

mg BID or TID for another month

• Copper deficiency • S/S - weakness, fatigue, skin sores,

and hair and skin discoloration

• Dx – low levels of copper

• Tx - oral copper 2 to 4 mg/d for 1 month.

Page 38: Morbid Obesity & Bariatric Surgery: What do we know?

Deficiencies

• Vitamin A deficiency • S/S - night blindness, dry eyes, dry

skin, and dry hair

• Dx - low serum vitamin A level

• Tx - oral vitamin A 5000 to 10,000 IU/d for 1 month• Refractory – increase dosage to

50,000 IU/d for 1 month

Page 39: Morbid Obesity & Bariatric Surgery: What do we know?

What does Bariatric Surgery help?

• Reduce Hgb A1c in diabetic patients

• Improve/eliminate high blood pressure

• Improve/eliminate OSA/CPAP use

• Improve joint health/pain

• Decrease # of medications

• Breath easier

Page 40: Morbid Obesity & Bariatric Surgery: What do we know?

Components of Effective Weight Management Programs

Nutrition

Physical Activity

Surgery

Behavior Modification

Healthy Weight

Loss

Page 41: Morbid Obesity & Bariatric Surgery: What do we know?

THANK YOU

Visit our website to view patients’ stories and pictures before

& after surgery.

www.gottolose.org

Dr. Jessica Gonzalez Hernandez

135 Commonwealth Dr, Suite 210

Greenville, SC 29615

Phone (864) 675-4819 Fax (864) 675-4836

Page 42: Morbid Obesity & Bariatric Surgery: What do we know?

References

1. NHLBI. 2013. Managing Overweight and Obesity in Adults: Systematic Evidence Review from the Obesity Expert Panel

2. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. pdf

3. Heber D, Greenway FL, Kaplan LM, et al. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2010;95:4823.

4. Aills L, Blankenship J, Buffington C, et al. ASMBS allied health nutritional guidelines for the surgical weight loss patient. SurgObes Relat Dis 2008;4:S73.

5. Norris Sl, Zhang X, Avenell A et al: Long-term non-pharmacological weight loss interventions for adults with prediabetes. Cochrane Database Syst Rev 2005.

6. Mann T, Tomiyama AJ, Westling e et al: Medicare’s search for effective obesity treatments: diets are not the answer. Am Psychol 2007;62:220–233.

7. Buchwald H, Avidor Y, Braunwald e et al: Bariatric surgery: A systematic review and meta-analysis. JAMA 2004;292:1724–1737.

8. DeMaria EJ: Bariatric surgery for morbid obesity. N Engl J Med 2007;356:2176–2183.

9. Sjostrom l, Lindroos AK, Peltonen M et al: Lifestyle, Diabetes, and Cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683–2693.